Report: Majority of Massachusetts Cannabis Consumers Using Licensed Stores
- In 2023, 73% of cannabis consumers in Massachusetts purchased products from licensed dispensaries, according to the Massachusetts Cannabis Control Commission's report using data from the International Cannabis Policy Study.
- For the first time, a majority (61%) of respondents reported sourcing cannabis from licensed retailers, while 56% obtained it from friends or family, and 24% from dealers.
- In 2023, 43% of Massachusetts residents consumed cannabis, with 17% reporting daily or near-daily use; flower was the most popular product (74%), followed by edibles (72%) and vapes (40%).
- More than half of consumers used cannabis to manage physical health (51%) or mental health (43%) concerns, with a small percentage reporting use before work (13%) or driving after consumption (14%), and only 9% sought medical help for adverse effects.
A report released this month by the Massachusetts Cannabis Control Commission (CCC) found that in 2023, 73% of cannabis consumers purchased products from licensed dispensaries. The study used data from the International Cannabis Policy Study (ICPS), conducted from 2019 to 2023.
For the first time in the ACPS survey, a majority – 61% – reported sourcing their cannabis from a licensed retailer, with 56% saying they obtained cannabis from a family member or friend, and 24% reporting obtaining cannabis from a “dealer.”
According to the report, 37% of Massachusetts residents consumed cannabis in the last year, including 43% in 2023. Another 14% reported daily or near-daily cannabis consumption, including 17% in 2023.
Flower was the most commonly used cannabis product (74% of respondents) during the study period, followed by edibles (72%), and vapes (40%).
A majority of cannabis consumers – 51% – said they used cannabis to manage or improve physical health concerns, while 43% said they consumed cannabis to manage mental health concerns.
Just 13% of respondents admitted to consuming cannabis at or before work during the previous 30 days. A similar share – 14% – said they had driven after consuming cannabis.
Just 9% of respondents reported seeking medical services to treat adverse health effects related to cannabis consumption.